- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Lybrate Raises $10.2 million from Ratan Tata and others
NEW DELHI: It seems like a good year for internet based- healthcare startups.
Healthcare communication and delivery startup Lybrate on Wednesday announced that it has received a series A funding of $10.2 million from Ratan Tata, Tiger Global and Nexus Venture Partners.
The startup, which enables patients to anonymously communicate with doctors via a mobile app or online from anywhere and anytime, plans to utilize the funds for product development, recruitment and augmenting technology and scale operations, it said in a statement.
It seems like the investors have strong faith in the business model of Lybrate. Tiger Global partner Lee Fixel was quoted as saying: "Lybrate's concept is ground-breaking. We believe it has the potential to revolutionize healthcare delivery in India and script the future of the healthcare industry with its model."
Founded in 2013 by Saurabh Arora, a former Facebook employee in the US, Lybrate aims to address the fundamental healthcare delivery problems in India, inaccessibility and self-medication, the statement added.
"We ignore our health and rush to take a call at delayed stages when the disease has progressed to serious levels. The tendency to consult chemists because of time constraint and inertia to visit a doctor is rampant and leads to risky behaviour of self-medication," said Arora.
The ability to remain anonymous enables people to talk health problems ranging from sexual health, women's health, psychological problems and depression, he added.
Since the launch of Lybrate App in January 2015, it was downloaded 500,000 times and over 100,000 patients are visiting the platform everyday where 80,000 doctors from various specialties across India are connected, the statement said.
Lybrate is scrutinizing every doctor's license and credentials before allowing them onto the platform, it added.
The startup, which enables patients to anonymously communicate with doctors via a mobile app or online from anywhere and anytime, plans to utilize the funds for product development, recruitment and augmenting technology and scale operations, it said in a statement.
It seems like the investors have strong faith in the business model of Lybrate. Tiger Global partner Lee Fixel was quoted as saying: "Lybrate's concept is ground-breaking. We believe it has the potential to revolutionize healthcare delivery in India and script the future of the healthcare industry with its model."
Founded in 2013 by Saurabh Arora, a former Facebook employee in the US, Lybrate aims to address the fundamental healthcare delivery problems in India, inaccessibility and self-medication, the statement added.
"We ignore our health and rush to take a call at delayed stages when the disease has progressed to serious levels. The tendency to consult chemists because of time constraint and inertia to visit a doctor is rampant and leads to risky behaviour of self-medication," said Arora.
The ability to remain anonymous enables people to talk health problems ranging from sexual health, women's health, psychological problems and depression, he added.
Since the launch of Lybrate App in January 2015, it was downloaded 500,000 times and over 100,000 patients are visiting the platform everyday where 80,000 doctors from various specialties across India are connected, the statement said.
Lybrate is scrutinizing every doctor's license and credentials before allowing them onto the platform, it added.
Lybrate competes with the likes of Practo , HelpingDoc, Praxify, AllizHealth and others. A few months back Practo had also raised around $30 million from Sequoia Capital and Matrix Partners.
Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She is a member of the Association of Healthcare Journalists. She can be contacted at meghna@medicaldialogues.in. Contact no. 011-43720751
Next Story